Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
The Journal of the American Osteopathic Association|June 6, 2002
The new "lower is better" lipid goals: are they achievable with today's drugs?Robert J ChiltonThe Journal of the American Osteopathic Association|July 30, 2003
Lipid and nonlipid benefits of statinsRobert J ChiltonDiabetes, Obesity & Metabolism|August 14, 2019
Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetesRobert J ChiltonThe Journal of the American Osteopathic Association|October 7, 2004
Pathophysiology of coronary heart disease: a brief reviewRobert J ChiltonThe Journal of the American Osteopathic Association|September 29, 2001
Recent discoveries in assessment of coronary heart disease: impact of vascular mechanisms on development of atherosclerosisR J ChiltonDiabetes, Obesity & Metabolism|October 28, 2010
Cardiovascular risk and thiazolidinediones--what do meta-analyses really tell us?G Schernthaner, R J ChiltonCardiovascular Therapeutics|December 21, 2010
The cardiovascular effects of GLP-1 receptor agonistsTheodore Okerson, Robert J ChiltonRadiology|November 1, 1978
Pulmonary varix in early infancy: case report with 8-year follow upS J Chilton, J B CampbellThe British Journal of Radiology|September 1, 1983
Ultrasound diagnosis of CSF cystic lesions in the neonatal brainS J Chilton, B J CreminClinical Therapeutics|October 14, 2003
Type 2 diabetes, cardiovascular risk, and the link to insulin resistanceMark W Stolar, Robert J ChiltonPageof 8